期刊文献+

过敏性紫癜患儿血小板表面黏附分子CD62P和GPⅡb/Ⅲa表达水平的变化 被引量:3

Levels of CD62P and GPⅡb/Ⅲa in children with henoch schonlein purpura
原文传递
导出
摘要 目的了解过敏性紫癜(HSP)患儿血小板表面黏附分子CD62P、GPⅡb/Ⅲa的表达情况,探讨其在HSP发病机制中的作用。方法选择2006年3-11月我院收治的29例HSP患儿,选择同期27例外科非感染性疾病患儿作为对照,应用流式细胞仪检测外周血小板黏附分子CD62P、GPⅡb/Ⅲa的水平。结果与对照组比较,HSP组血小板GPⅡb/Ⅲa表达水平为(26.30±10.25)%,比对照组的(20.67±7.80)%明显增高(P﹤0.05),且HSP肾炎者[(29.43±10.10)%]明显高于HSP非肾炎者[(21.18±8.72)%,P﹤0.05];HSP组与对照组CD62P分子的表达水平分别为(1.33±0.40)%和(1.24±0.41)%,两组比较无显著性差异(P=0.43)。结论HSP患儿血小板GPⅡb/Ⅲa表达增加,尤以合并肾脏损害时明显。血小板的异常活化参与了HSP、过敏性紫癜肾炎(HSPN)发病的病理生理过程。 Objective To detect the expression of platelet surface glycoproteins GP Ⅱ b/Ⅲa and CD62P and to explore their effect in the pathogenesis of HSP. Methods 29 HSP patients and 27 control cases were enrolled in this study. HSP patients were devided into nephritis group and non-nephritis group. The expression of GP Ⅱ b/Ⅲa and CD62P in platelets were examined by flow cytometry. Results Compared to the control [ (20.67±7.80)% ], the expression of GPⅡ b/Ⅲa in HSP group [(:26.30±10.25)% ] was significantly increased (P 〈 0.05), and the level of nephrits group was significantly higher than that of non-nephrits group (P 〈 0.05), while the expression of CD62P in HSP group was not significantly different from that in control (P=0.43). Conclusions The expression of GP IⅡ b/Ⅲa in HSP group significantly increased, especially in those with renal involvement. The aberrant activation of platelets may play a role in the pathogenesis of HSP and HSPN.
出处 《北京医学》 CAS 2008年第11期661-663,共3页 Beijing Medical Journal
关键词 过敏性紫癜 黏附分子 患者 临床分析 Henoch schonlein purura Adhesion molecule
  • 相关文献

参考文献9

二级参考文献33

  • 1王亚萍,沈辉君,刘爱民.儿童过敏性紫癜288例临床分析[J].中华皮肤科杂志,2005,38(7):453-454. 被引量:15
  • 2孙林,叶任高,李幼姬,陈康联,于黔.系膜增殖性肾炎患者肾生存率的研究[J].中华肾脏病杂志,1996,12(6):359-362. 被引量:18
  • 3孙晓明,尹格平.实体瘤组织细胞粘附分子流式细胞研究方法的建立[J].中华医学检验杂志,1997,20(1):9-11. 被引量:38
  • 4高燕 李小峰 杨林花 等.系统性红斑狼疮患者血小板GMP140变化及临床意义初探[J].中华风湿病学杂志,2000,4(1):58-59.
  • 5Balduini CL.Defect aggregation and adhesion induced by autoantibodies against platelet GP Ⅱb/Ⅲa.Thromb Haemost,1992,68:208-213.
  • 6Richert-Boe KE.Hematologic complication of rheumatic disease.Hematol Oncol,1987,1:301-320.
  • 7Tayebeh Y,Jean-Masse E,Francine R,et al.Platelet and megakaryocyte dense granules contain glycoproteins GPⅡb/Ⅲa.Blood,1997,89:407-4057.
  • 8Shall SJ.Changes in the platelet membrane glycoprotein GPⅡb/Ⅲa complex during platelet activation.J Biol Chem,1985,260:1107-1112.
  • 9Jennings LK,Ashumn RA,Wang WC,et al.Analysis of human platelet glycoproteins GPⅡb/Ⅲa and Glanzamann′s thrombasthenin in whole blood by flow cytometry.Blood,1996,88:173-179.
  • 10Kubota T,Tanoue K,Murohashi I,et al.Autoantibody against platelet glycoprotein GPⅡb/Ⅲa in a patient with non- Hodgkin′s lymphoma.Thromb Res,1989,53:379-386.

共引文献1564

同被引文献62

引证文献3

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部